Isocare

Isocare Uses, Dosage, Side Effects, Food Interaction and all others data.

Red clover Isoflavones are a naturally occurring element with a chemical structure similar to that of steroidal estrogens. Isoflavones mimic the human bodies’ natural estrogen. As a result, red clover Isoflavones interact with the human estrogen receptor. Red clover Isoflavones preferentially activate the beta estrogen receptors found in the brain, bones and cardiovascular system. Red clover Isoflavones show very little activity in the alpha estrogen receptors found in breast and uterine tissue.

Isocare
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Isocare
Generic	Red Clover Isoflavones
Type	Tablet
Therapeutic Class
Manufacturer	Finecure Pharmaceuticals
Available Country	India
Last Updated:	September 19, 2023 at 7:00 am

Uses

Isocare is used for menopausal women, for the relief of menopause symptoms.

It Helps to relieve symptoms of menopause such as hot flushes and night sweats Menopause related osteoporosis and bone density loss Maintenance of cholesterol level

Dosage

Isocare dosage

The recommended dosage is 1-2 capsules per day depending on body weight and on the severity of symptoms. Each capsule should be taken with a meal and at approximately the same time each day.

Precaution

No adverse reactions are known at the recommended dosage. Animal data showed that excessive may reduce fertility.

Interaction

Efficacy of Tamoxifen is decreased if it is used concomitantly with red clover. Caution is advised if anti-coagulants, contraceptives, estrogen and progesterone like drugs are used with red clover.

Pregnancy & Breastfeeding use

Not recommended for use during pregnancy. Isoflavones are secreted in breast milk, so use during lactation is not recommended.

Contraindication

It is recommended that the diet should not be supplemented with Isoflavonoid phytoestrogens during therapy with reproductive hormones including estrogen, progestogen and androgen because of the potential risk of competitive inhibition.